Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05779488
Other study ID # N202103118
Secondary ID MOST110-2410-H-0
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 14, 2022
Est. completion date December 2023

Study information

Verified date February 2023
Source Taipei Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate Lepidium meyenii (Maca) extract supplementation on exercise-induced responses of the biochemical, and physiological parameters.


Description:

Thirty healthy male participants were divided into Maca group (2.25 g of Maca extract, twice per day for 12 weeks) and placebo group (n = 15). All participants conducted a graded exercise test on treadmill to determine the maximal oxygen consumption (VO2max) before and after supplementation, and the speed equivalent to 70% VO2max was conducted for an exhaustive endurance exercise test by treadmill for 1 hours, followed by 90% VO2max until exhaustion.The time to exhaustion, peak oxygen consumption, maximal heart rate and average heart rate will be recorded during the exercise period. Venous blood samples will be drawn before, immediately after, 2-hour after, 4-hour after, and 24-hour after the exhaustive endurance exercise test. Data was analyzed by Two-way mixed design ANOVA.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: - The volunteers included have conditions as stated below : 1. male adult whose no history of cardiovascular, liver, kidney and diabetes disease 2. no acute sport injury 3. did not participated in any clinical trials or research in the last 3 months before our experiment 4. no supplements were taken during the experimental period 5. were requested to maintain their regular daily life style and avoid alcohol intake Exclusion Criteria: - The volunteers were excluded if they have the situation stated below: 1. history of cardiovascular, liver, kidney and diabetes disease 2. acute sport injury 3. participated in any clinical trials or experimental research in the last 3 months before our experiment 4. taking supplement during the experimental period 5. did not maintain their regular eating habit or drink alcohol

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
maca
2.25 g of Maca extract, twice per day for 12 weeks
placebo
2.25 g of starch, twice per day for 12 weeks

Locations

Country Name City State
Taiwan Taipei Medical University Taipei

Sponsors (2)

Lead Sponsor Collaborator
Taipei Medical University Panion & BF Biotech Inc.

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concentration of leukocyte before exercise
Primary Concentration of leukocyte immediately after exercise
Primary Concentration of leukocyte 2-hour after exercise
Primary Concentration of leukocyte 4-hour after exercise
Primary Concentration of leukocyte 24-hour after exercise
Primary Concentration of neutrophil before exercise
Primary Concentration of neutrophil immediately after exercise
Primary Concentration of neutrophil 2-hour after exercise
Primary Concentration of neutrophil 4-hour after exercise
Primary Concentration of neutrophil 24-hour after exercise
Primary Concentration of lymphocyte beore exercise
Primary Concentration of lymphocyte immediately after exercise
Primary Concentration of lymphocyte 2-hour after exercise
Primary Concentration of lymphocyte 4-hour after exercise
Primary Concentration of lymphocyte 24-hour after exercise
Primary Concentration of GSH before exercise
Primary Concentration of GSH immediately after exercise
Primary Concentration of GSH 2-hour after exercise
Primary Concentration of GSH 4-hour after exercise
Primary Concentration of GSH 24-hour after exercise
Primary Concentration of CD4+ before exercise
Primary Concentration of CD4+ immediately after exercise
Primary Concentration of CD4+ 2-hour after exercise
Primary Concentration of CD4+ 4-hour after exercise
Primary Concentration of CD4+ 24-hour after exercise
Primary Concentration of CD8+ before exercise
Primary Concentration of CD8+ immediately after exercise
Primary Concentration of CD8+ 2-hour after exercise
Primary Concentration of CD8+ 4-hour after exercise
Primary Concentration of CD8+ 24-hour after exercise
Primary Concentration of CD19+ before exercise
Primary Concentration of CD19+ immediately after exercise
Primary Concentration of CD19+ 2-hour after exercise
Primary Concentration of CD19+ 4-hour after exercise
Primary Concentration of CD19+ 24-hour after exercise
Primary Concentration of CD56+ before after exercise
Primary Concentration of CD56+ immediately after exercise
Primary Concentration of CD56+ 2-hour after exercise
Primary Concentration of CD56+ 4-hour after exercise
Primary Concentration of CD56+ 24-hour after exercise
Primary IConcentration of GSSG before exercise
Primary Concentration of GSSG immediately after exercise
Primary Concentration of GSSG 2-hour after exercise
Primary Concentration of GSSG 4-hour after exercise
Primary Concentration of GSSG 24-hour after exercise
Primary Concentration of CK-MB before exercise
Primary Concentration of CK-MB 2-hour after exercise
Primary Concentration of CK-MB 4-hour after exercise
Primary Concentration of CK-MB 24-hour after exercise
Primary Concentration of CK-MB immediately after exercise
Primary Concentration of TNF-a before exercise
Primary Concentration of TNF-a immediately after exercise
Primary Concentration of TNF-a 2-hour after exercise
Primary Concentration of TNF-a 4-hour after exercise
Primary Concentration of TNF-a 24-hour after exercise
Primary Concentration of IL-1ß before exercise
Primary Concentration of IL-1ß immediately after exercise
Primary Concentration of IL-1ß 2-hour after exercise
Primary Concentration of IL-1ß 4-hour after exercise
Primary Concentration of IL-1ß 24-hour after exercise
Primary Concentration of IFN-? before exercise
Primary Concentration of IFN-? immediately after exercise
Primary Concentration of IFN-? 2-hour after exercise
Primary Concentration of IFN-? 4-hour after exercise
Primary Concentration of IFN-? 24-hour after exercise
Primary Concentration of IL-2 before exercise
Primary Concentration of IL-2 immediately after exercise
Primary Concentration of IL-2 2-hour after exercise
Primary Concentration of IL-2 4-hour after exercise
Primary Concentration of IL-2 24-hour after exercise
Primary Concentration of IL-4 before exercise
Primary Concentration of IL-4 immediately after exercise
Primary Concentration of IL-4 2-hour after exercise
Primary Concentration of IL-4 4-hour after exercise
Primary Concentration of IL-4 24-hour after exercise
Primary Concentration of IL-8 before exercise
Primary Concentration of IL-8 immediately after exercise
Primary Concentration of IL-8 2-hour after exercise
Primary Concentration of IL-8 4-hour after exercise
Primary Concentration of IL-8 24-hour after exercise
Primary Concentration of IL-10 before exercise
Primary Concentration of IL-10 immediately after exercise
Primary Concentration of IL-10 2-hour after exercise
Primary Concentration of IL-10 4-hour after exercise
Primary Concentration of IL-10 24-hour after exercise
Primary Concentration of TBARS before exercise
Primary Concentration of TBARS immediately after exercise
Primary Concentration of TBARS 2-hour after exercise
Primary Concentration of TBARS 4-hour after exercise
Primary Concentration of TBARS 24-hour after exercise
Primary Concentration of PC before exercise
Primary Concentration of PC immediately after exercise
Primary Concentration of PC 2-hour after exercise
Primary Concentration of PC 4-hour after exercise
Primary Concentration of PC 24-hour after exercise
Primary Concentration of SOD before exercise
Primary Concentration of SOD immediately after exercise
Primary Concentration of SOD 2-hour after exercise
Primary Concentration of SOD 4-hour after exercise
Primary Concentration of SOD 24-hour after exercise
Primary Concentration of catalase before exercise
Primary Concentration of catalase immediately after exercise
Primary Concentration of catalase 2-hour after exercise
Primary Concentration of catalase 4-hour after exercise
Primary Concentration of catalase 24-hour after exercise
Primary Concentration of GPx before exercise
Primary Concentration of GPx immediately after exercise
Primary Concentration of GPx 2-hour after exercise
Primary Concentration of GPx 4-hour after exercise
Primary Concentration of GPx 24-hour after exercise
Primary Concentration of CK before exercise
Primary Concentration of CK immediately after exercise
Primary Concentration of CK 2-hour after exercise
Primary Concentration of CK 4-hour after exercise
Primary Concentration of CK 24-hour after exercise
Primary Concentration of LDH before exercise
Primary Concentration of LDH immediately after exercise
Primary Concentration of LDH 2-hour after exercise
Primary Concentration of LDH 4-hour after exercise
Primary Concentration of LDH 24-hour after exercise
Primary Concentration of IL-6 before exercise
Primary Concentration of IL-6 immediately after exercise
Primary Concentration of IL-6 2-hour after exercise
Primary Concentration of IL-6 4-hour after exercise
Primary Concentration of IL-6 24-hour after exercise
Primary Concentration of cTnI before exercise
Primary Concentration of cTnI immediately after exercise
Primary Concentration of cTnI 2-hour after exercise
Primary Concentration of cTnI 4-hour after exercise
Primary Concentration of cTnI 24-hour after exercise
Primary Concentration of NT proBNP before exercise
Primary Concentration of NT proBNP immediately after exercise
Primary Concentration of NT proBNP 2-hour after exercise
Primary Concentration of NT proBNP 4-hour after exercise
Primary Concentration of NT proBNP 24-hour after exercise
Primary Concentration of testosterone before exercise
Primary Concentration of testosterone immediately after exercise
Primary Concentration of testosterone 2-hour after exercise
Primary Concentration of testosterone 4-hour after exercise
Primary Concentration of testosterone 24-hour after exercise
Primary Concentration of LH before exercise
Primary Concentration of LH immediately after exercise
Primary Concentration of LH 2-hour after exercise
Primary Concentration of LH 4-hour after exercise
Primary Concentration of LH 24-hour after exercise
Primary Concentration of FSH before exercise
Primary Concentration of FSH immediately after exercise
Primary Concentration of FSH 2-hour after exercise
Primary Concentration of FSH 4-hour after exercise
Primary Concentration of FSH 24-hour after exercise
Primary Concentration of NO before exercise
Primary Concentration of NO immediately after exercise
Primary Concentration of NO 2-hour after exercise
Primary Concentration of NO 4-hour after exercise
Primary Concentration of NO 24-hour after exercise
Primary Concentration of GOT before exercise
Primary Concentration of GOT immediately after exercise
Primary Concentration of GOT 2-hour after exercise
Primary Concentration of GOT 4-hour after exercise
Primary Concentration of GOT 24-hour after exercise
Primary Concentration of GPT before exercise
Primary Concentration of GPT immediately after exercise
Primary Concentration of GPT 2-hour after exercise
Primary Concentration of GPT 4-hour after exercise
Primary Concentration of GPT 24-hour after exercise
Primary Concentration of BUN before exercise
Primary Concentration of BUN immediately after exercise
Primary Concentration of BUN 2-hour after exercise
Primary Concentration of BUN 4-hour after exercise
Primary Concentration of BUN 24-hour after exercise
Primary Concentration of creatinine before exercise
Primary Concentration of creatinine immediately after exercise
Primary Concentration of creatinine 2-hour after exercise
Primary Concentration of creatinine 4-hour after exercise
Primary Concentration of creatinine 24-hour after exercise
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1